$34.670
-2.260 (-6.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
COGT Prediction & Forecast by Similar Chart Analysis
Alphio's COGT stock price prediction model matches the current Cogent Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $34.36 (-0.88%). The 1-week path is $32.74 (-5.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cogent Biosciences Inc Stock?
Cogent Biosciences Inc is a good buy right now due to its promising pipeline, particularly the NDA submission for Bezuclastinib, which has shown significant efficacy in clinical trials. The current price of $34.67 is well below the analyst price target of $52, suggesting a potential upside of 50%. Additionally, the RSI is at 27.571, indicating that the stock is oversold and may be due for a rebound. However, the main risk is the company's ongoing net losses, with a net income of -88,932,000 USD in Q2 2026, which could impact future performance if not addressed.
COGT stock price ended at $34.67 on Friday, after losing -6.52%
Cogent Biosciences Inc (COGT) last closed at $34.67, losing -6.52%. These facts feed the 1-day and 1-week COGT price prediction above.
Analyst Consensus
Cogent Biosciences Inc (COGT): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Cogent Biosciences Inc (COGT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches COGT, ranked by similarity.
Seasonality analysis for COGT
Historically the probability of a positive August return for COGT is 96.88%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for COGT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $8.76 | $11.15 | $12.33 | -67.85% |
| Sep 2026 | $13.46 | $15.07 | $16.66 | -56.52% |
| Oct 2026 | $10.75 | $11.15 | $13.16 | -67.85% |
| Nov 2026 | $11.88 | $15.08 | $16.50 | -56.50% |
| Dec 2026 | $10.02 | $11.72 | $13.42 | -66.20% |
In 2026, Cogent Biosciences Inc (COGT) is projected to range from $8.76 to $16.66.
Cogent Biosciences Inc 2026 monthly forecast
In Aug 2026, Cogent Biosciences Inc is projected to average $11.15, with a low of $8.76 and high of $12.33.
In Sep 2026, Cogent Biosciences Inc is projected to average $15.07, with a low of $13.46 and high of $16.66.
In Oct 2026, Cogent Biosciences Inc is projected to average $11.15, with a low of $10.75 and high of $13.16.
In Nov 2026, Cogent Biosciences Inc is projected to average $15.08, with a low of $11.88 and high of $16.50.
In Dec 2026, Cogent Biosciences Inc is projected to average $11.72, with a low of $10.02 and high of $13.42.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.